Status:
COMPLETED
Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss
Lead Sponsor:
University of British Columbia
Conditions:
Female Pattern Hair Loss
Eligibility:
FEMALE
18-75 years
Phase:
PHASE2
Brief Summary
This study evaluates the efficacy of therapy with the anti-androgen spironolactone compared to topical minoxidil in female pattern hair loss.
Eligibility Criteria
Inclusion
- Subjects must be premenopausal women older than 18 with female pattern hair loss.
Exclusion
- Androgen excess
- Other scalp or hair disorders
- Contraindications to spironolactone treatment, especially pregnancy, electrolyte imbalances, history of breast cancer, or intake of interfering drugs
- Contraindications to minoxidil treatment, especially patients who are allergic to this treatment or have a history of low blood pressure or irregular heart beats
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 9 2009
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00175617
Start Date
September 1 2005
End Date
March 9 2009
Last Update
March 3 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UBC Division of Dermatology, Hair Research and Treatment Centre
Vancouver, British Columbia, Canada, V6G 1Y6